Symfi Cost Without Insurance — US Pharmacy Price Guide

Our most recent US pharmacy data shows a low of roughly $556.04 for Efavirenz-Lamivudine-Tenofovir with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Yes — Cost Plus Drugs lists Efavirenz-Lamivudine-Tenofovir at roughly $27.42 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.

Generic and brand-name pricing for Efavirenz-Lamivudine-Tenofovir is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

Many health insurance plans, including Medicare Part D, typically cover Symfi. The out-of-pocket cost for insured patients will depend on their specific plan's formulary, deductible, copayment, and coinsurance requirements. Patients with high out-of-pocket costs or those without adequate coverage may explore patient assistance programs like ADAP and HarborPath. In some cases, using a prescription discount program may also help lower the cost at the pharmacy.

Symfi is generally covered by Medicare Part D plans. The exact cost to a Medicare beneficiary depends on their specific plan's design, including any deductibles, copayments, or coinsurance. Patients facing affordability challenges despite Medicare coverage can investigate patient assistance programs, such as ADAP and HarborPath, or inquire about prescription discount options at their pharmacy.

Symfi is a generic medication. It is a fixed-dose combination product containing the active ingredients efavirenz, lamivudine, and tenofovir disoproxil fumarate. There is no distinct brand-name version of this specific three-drug combination.